OBJECTIVE: To evaluate the prevalence of metabolic syndrome and its components in normal and complicated pregnancies. SETTING: university hospital, tertiary referral centre. SUBJECTS: 90 pregnant women in four groups: 20 women with preeclampsia, 20 women with gestational hypertension, 30 women with late-onset gestational diabetes and 20 healthy pregnant women as a control group. INTERVENTION: peripheral insulin resistance was measured by using the insulin tolerance test. Glucose, triglycerides, high-density lipoprotein cholesterol, blood pressure and body mass index were analysed. Comparisons were done by Chi-squared test, one-way analysis of variance and the Bonferroni's test. Prevalence of the metabolic syndrome was calculated by adapting both the WHO and the NCEP definitions of the metabolic syndrome to pregnancy. RESULTS: There were no cases of metabolic syndrome in the control group according to any of the adapted definitions. The prevalence of this syndrome was 3.3% and 10% in the late-onset gestational diabetes group, 35% and 20% in the gestational hypertension group and 30% and 30% in the preeclampsia group for the WHO and the NCEP definitions, respectively. CONCLUSIONS: Metabolic syndrome is present in about one-third of women with pregnancy-induced hypertension but only in 10% of women with late-onset gestational diabetes.
OBJECTIVE: To evaluate the prevalence of metabolic syndrome and its components in normal and complicated pregnancies. SETTING: university hospital, tertiary referral centre. SUBJECTS: 90 pregnant women in four groups: 20 women with preeclampsia, 20 women with gestational hypertension, 30 women with late-onset gestational diabetes and 20 healthy pregnant women as a control group. INTERVENTION: peripheral insulin resistance was measured by using the insulin tolerance test. Glucose, triglycerides, high-density lipoprotein cholesterol, blood pressure and body mass index were analysed. Comparisons were done by Chi-squared test, one-way analysis of variance and the Bonferroni's test. Prevalence of the metabolic syndrome was calculated by adapting both the WHO and the NCEP definitions of the metabolic syndrome to pregnancy. RESULTS: There were no cases of metabolic syndrome in the control group according to any of the adapted definitions. The prevalence of this syndrome was 3.3% and 10% in the late-onset gestational diabetes group, 35% and 20% in the gestational hypertension group and 30% and 30% in the preeclampsia group for the WHO and the NCEP definitions, respectively. CONCLUSIONS:Metabolic syndrome is present in about one-third of women with pregnancy-induced hypertension but only in 10% of women with late-onset gestational diabetes.
Authors: Alfred O Osoti; Stephanie T Page; Barbra A Richardson; Brandon L Guthrie; John Kinuthia; Stephen J Polyak; Carey Farquhar Journal: Pregnancy Hypertens Date: 2019-08-19 Impact factor: 2.899
Authors: Mohammed Al Thani; Al Anoud Al Thani; Walaa Al-Chetachi; Badria Al Malki; Shamseldin A H Khalifa; Ahmad Haj Bakri; Nahla Hwalla; Lara Nasreddine; Farah Naja Journal: Int J Mol Sci Date: 2016-06-02 Impact factor: 5.923
Authors: Miriam Leitner; Lena Fragner; Sarah Danner; Nastassja Holeschofsky; Karoline Leitner; Sonja Tischler; Hannes Doerfler; Gert Bachmann; Xiaoliang Sun; Walter Jaeger; Alexandra Kautzky-Willer; Wolfram Weckwerth Journal: Front Mol Biosci Date: 2017-12-21
Authors: I C Rodrigues; C Grandi; V M F Simões; R F L Batista; L S Rodrigues; V C Cardoso Journal: Braz J Med Biol Res Date: 2020-12-07 Impact factor: 2.590
Authors: Ana Alzamendi; Hector Del Zotto; Daniel Castrogiovanni; Jose Romero; Andres Giovambattista; Eduardo Spinedi Journal: ISRN Endocrinol Date: 2012-08-16
Authors: Hamilton Dos Prazeres Tavares; Débora Cristina Damasceno Meirelles Dos Santos; Joelcio Francisco Abbade; Carlos Antonio Negrato; Paulo Adão de Campos; Iracema Mattos Paranhos Calderon; Marilza Vieira Cunha Rudge Journal: Diabetol Metab Syndr Date: 2016-03-22 Impact factor: 3.320